WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), in order to more effectively support its global growth plans, announced that it is realigning the responsibilities of its senior management team. These changes are intended to facilitate globalization of Encorium through expansion of the Company’s worldwide service offerings with a focus on sustained revenue growth and profitability. Dr. Kenneth M. Borow is currently President of Encorium Group, Inc. as well as Chief Executive Officer. In order to allow Dr. Borow to focus more of his time on the expansion of the Company’s Consultancy Services business and its Global Business Development initiatives, the responsibilities of Chief Executive Officer have been transferred as of today to Dr. Kai Lindevall, presently Encorium’s President of Operations for Europe and Asia. Dr. Borow will remain President of the Company as well as assume the new position of Chief Medical and Strategic Development Officer.
